StockChartsAI.com
All Chart Prices Delayed at least 15 minutesBefore accessing this site, you agree that you have read and agree to the disclaimers at the bottom of this page.
Stock Charts AI Power Rank: 9.4
Power Rank trend -> Rising
09/06/2024 16:21:00 EST
Teleflex Incorporated (TFX)
Industry: Medical Instruments & Supplies
Follow @stockchartsai on TwitterPrice Support Resistance
In the past 20 trading days, TFX has been trading in a range between $245.17 and $227.98 (gray range band). Red lines on the chart represent key resistance levels and Green lines represent key support levels. As the price moves above the lines you will notice they turn green and red if price moves below a line.
TFX is trading below resistance at $255.05, about 4% to the upside. There is support at $235.95 -4% to the downside. If it can break above the resistance, it could have some more upside. If the price starts to turn down and fails to get through this level or enters a yellow zone, we would consider profit taking or exiting the position. If it enters a red zone on the chart we would exit the position.
Upside / Downside Potential
Teleflex Incorporated $TFX entered a Green zone 65 days ago on the AI powered stock chart. Wall Street analysts have an AVG target price $252.25, a potential upside of 3.16% from the recent price of 244.53. The stock is trading 4.96% (potential upside) below its 52 week high of $256.66 and 38.53 % (potential downside) above its 52 week low of $176.52 - based on the recent price.
Company Summary
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. It also offers interventional products, which consists of various coronary catheters, structural heart support devices, and peripheral intervention and mechanical circulatory support platform that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded pumps and catheters, Guideline, Turnpike, and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices.
News
| TFX or PEN: Which Is the Better Value Stock Right Now? Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and Penumbra (PEN). But which of these two stocks offers value investors a better bang for their buck right now? Source: Zacks Investment Research Wed, 04 Sep 2024 12:41:08 -0400 Sentiment: Neutral |
| Teleflex's (TFX) Titan SGS Stapler Showcases Positive Outcomes Teleflex (TFX) publishes an analysis of clinical data showcasing the Titan SGS Stapler's enhanced clinical outcomes and significant efficiency benefits. Source: Zacks Investment Research Mon, 26 Aug 2024 12:45:53 -0400 Sentiment: Positive |
| Teleflex to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference WAYNE, Pa., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Morgan Stanley 22nd Annual Global Healthcare Conference at the Marriott Marquis New York, on Friday, September 6, 2024, at 7:45 a.m. (ET). Source: GlobeNewsWire Thu, 22 Aug 2024 06:30:00 -0400 Sentiment: Neutral |
| Teleflex Announces Publication of a Propensity Matching Review of Retrospective Data Reporting that the Titan SGS™ Stapler Enables Consistent Gastric Pouch Formation with Fewer Variations, Providing Potentially Enhanced Clinical Outcomes and Significant Procedural Efficiency Compared with Traditional Surgical Staplers WAYNE, Pa., Aug. 21, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the publication of a new retrospective analysis of clinical data linking the Titan SGS™ Stapler with enhanced clinical outcomes and significant procedural efficiency benefits compared with multi-fire surgical staplers in patients undergoing laparoscopic sleeve gastrectomy (LSG).1 The study was conducted by five surgeons at a Corewell Health Hospital in Grand Rapids, MI, an MBSAQIP-accredited facility that is a Center of Excellence for bariatric surgery.* The study results appear in the current issue of Obesity Surgery .1 Source: GlobeNewsWire Wed, 21 Aug 2024 06:30:00 -0400 Sentiment: Neutral |
| TFX or EW: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Medical - Instruments sector might want to consider either Teleflex (TFX) or Edwards Lifesciences (EW). But which of these two companies is the best option for those looking for undervalued stocks? Source: Zacks Investment Research Mon, 19 Aug 2024 12:41:47 -0400 Sentiment: Positive |
Technicals 52 Week Hi: 256.6622 52 Week Low: 176.5198 Beta: 1.156 50 Day MA: 228.8146 200 Day MA: 226.6227 Earnings / Revenue Trends Qtr Earnings Growth YOY: -0.281 Qtr Revenue Growth YOY: 0.009 Forward PE: 15.5521 Trailing PE: 43.6661